Artemis Therapeutics Inc.
ATMS · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $66,187,608 | $24,832 | $1,107 | $144 |
| - Cash | $55 | $1 | $1 | $2 |
| + Debt | $356 | $196 | $110 | $103 |
| Enterprise Value | $66,187,909 | $25,027 | $1,216 | $245 |
| Revenue | $311 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $257 | $0 | $0 | $0 |
| % Margin | 82.6% | – | – | – |
| EBITDA | -$1,343 | -$154 | -$167 | -$168 |
| % Margin | -431.8% | – | – | – |
| Net Income | -$1,351 | -$180 | -$121 | -$121 |
| % Margin | -434.4% | – | – | – |
| EPS Diluted | -0.01 | -0.007 | -0.024 | -0.024 |
| % Growth | -44.9% | 70.6% | 0% | – |
| Operating Cash Flow | -$390 | -$73 | -$1 | -$108 |
| Capital Expenditures | -$26 | $0 | $0 | $0 |
| Free Cash Flow | -$416 | -$73 | -$1 | -$108 |